(28/05/2017)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 43 | 3 | 1 / 250% | 1 / 714.3% | 0 / 00% | 1 / 714.3% | | 5 | 6 | 1 | 7 | 7 | 1 | 0 | 7 | 4 |
(21/05/2017)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 00 | 6 | 0 / 00% | 3 / 933.3% | 0 / 00% | 3 / 933.3% | | 3 | 2 | 3 | 5 | 7 | 0 | 0 | 9 | 3 |
(14/05/2017)vs
ELNAVI | 00 | 10 | 0 / 60% | 5 / 1241.7% | 0 / 10% | 5 / 1338.5% | | 1 | 3 | 1 | 4 | 5 | 5 | 0 | 4 | 6 |
(07/05/2017)vs
ΠΗΓΑΣΟΣ | 00 | 9 | 3 / 837.5% | 3 / 650% | 0 / 00% | 3 / 650% | | 2 | 3 | 0 | 3 | 4 | 1 | 0 | 1 | 8 |
(22/04/2017)vs
ΠΟΛΙΤΙΣΤΙΚΟ ΚΕΝΤΡΟ ΕΡΓΑΖΟΜΕΝΩΝ Ε.ΥΔ.ΑΠ. | 00 | 2 | 0 / 00% | 1 / 425% | 0 / 00% | 1 / 425% | | 3 | 3 | 0 | 3 | 7 | 3 | 0 | 2 | 10 |
(09/04/2017)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 00 | 6 | 0 / 00% | 3 / 1127.3% | 0 / 00% | 3 / 1127.3% | | 1 | 1 | 0 | 1 | 2 | 1 | 0 | 3 | -1 |
(02/04/2017)vs
VITEX | 00 | 4 | 0 / 00% | 2 / 633.3% | 0 / 00% | 2 / 633.3% | | 1 | 2 | 1 | 3 | 7 | 0 | 0 | 4 | 6 |
(19/03/2017)vs
MINERVA MARINE | 00 | 2 | 0 / 00% | 1 / 1010% | 0 / 00% | 1 / 1010% | | 3 | 2 | 2 | 4 | 5 | 0 | 0 | 3 | -1 |
(05/03/2017)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 00 | 7 | 0 / 40% | 2 / 633.3% | 1 / 1100% | 3 / 742.9% | | 4 | 3 | 0 | 3 | 6 | 1 | 0 | 5 | 4 |
(19/02/2017)vs
ELNAVI | 00 | 4 | 0 / 00% | 2 / 366.7% | 0 / 00% | 2 / 366.7% | | 2 | 1 | 0 | 1 | 9 | 2 | 0 | 3 | 12 |
(11/02/2017)vs
ΠΗΓΑΣΟΣ | 00 | 3 | 1 / 1100% | 1 / 333.3% | 0 / 00% | 1 / 333.3% | | 1 | 1 | 1 | 2 | 0 | 1 | 0 | 2 | 2 |
(28/01/2017)vs
ΠΟΛΙΤΙΣΤΙΚΟ ΚΕΝΤΡΟ ΕΡΓΑΖΟΜΕΝΩΝ Ε.ΥΔ.ΑΠ. | 00 | 5 | 5 / 683.3% | 0 / 30% | 0 / 00% | 0 / 30% | | 1 | 4 | 1 | 5 | 13 | 0 | 0 | 5 | 14 |
(22/01/2017)vs
ΙΑΤΡΙΚΗ ΔΙΑΓΝΩΣΗ ΣΑΛΒΑΡΑ | 00 | 8 | 0 / 00% | 4 / 1428.6% | 0 / 00% | 4 / 1428.6% | | 2 | 1 | 1 | 2 | 1 | 0 | 0 | 4 | -3 |
(14/01/2017)vs
VITEX | 00 | 4 | 0 / 00% | 2 / 540% | 0 / 00% | 2 / 540% | | 0 | 3 | 0 | 3 | 6 | 1 | 0 | 1 | 10 |
(18/12/2016)vs
MINERVA MARINE | 21 | 4 | 0 / 00% | 2 / 728.6% | 0 / 00% | 2 / 728.6% | | 3 | 2 | 1 | 3 | 2 | 1 | 0 | 2 | 3 |
(11/12/2016)vs
ΚΑΤΣΕΛΗΣ | 00 | 3 | 3 / 650% | 0 / 20% | 0 / 00% | 0 / 20% | | 2 | 1 | 0 | 1 | 5 | 2 | 0 | 4 | 2 |
(04/12/2016)vs
ΑΣΤΡΟΝ ΧΗΜΙΚΑ | 00 | 17 | 5 / 683.3% | 6 / 1346.2% | 0 / 00% | 6 / 1346.2% | | 1 | 5 | 0 | 5 | 5 | 1 | 0 | 1 | 19 |
(27/11/2016)vs
OMS | 00 | 4 | 0 / 00% | 2 / 922.2% | 0 / 00% | 2 / 922.2% | | 3 | 3 | 2 | 5 | 6 | 0 | 0 | 2 | 6 |
(13/11/2016)vs
OMS | 00 | 5 | 1 / 425% | 2 / 728.6% | 0 / 00% | 2 / 728.6% | | 5 | 1 | 1 | 2 | 2 | 2 | 0 | 4 | -1 |
(06/11/2016)vs
PHARMACIA | 26 | 2 | 0 / 20% | 1 / 714.3% | 0 / 10% | 1 / 812.5% | | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 2 | -8 |
(16/10/2016)vs
OMS | 00 | 1 | 1 / 425% | 0 / 30% | 0 / 00% | 0 / 30% | | 4 | 4 | 1 | 5 | 5 | 1 | 0 | 3 | 3 |
(09/10/2016)vs
PHARMACIA | 00 | 2 | 0 / 00% | 1 / 812.5% | 0 / 10% | 1 / 911.1% | | 3 | 0 | 0 | 0 | 2 | 1 | 0 | 3 | -6 |
(02/10/2016)vs
ΚΑΤΣΕΛΗΣ | 40 | 9 | 3 / 475% | 3 / 933.3% | 0 / 00% | 3 / 933.3% | | 3 | 3 | 1 | 4 | 8 | 3 | 0 | 5 | 12 |
| ΣΥΝΟΛΙΚΑ |
130 |
120 |
23 / 5343.4% |
47 / 16428.7% |
1 / 425% |
48 / 16828.6% |
|
55 |
55 |
17 |
72 |
114 |
27 |
0 |
79 |
104 |
| ΜΕΣΟΙ ΟΡΟΙ |
5.7 |
5.2 |
1 / 2.343.4% |
2.0 / 7.128.7% |
0.0 / 0.225% |
2.1 / 7.328.6% |
|
2.4 |
2.4 |
0.7 |
3.1 |
5.0 |
1.2 |
0 |
3.4 |
4.5 |